Pathological gambling in Parkinson's disease: Subthalamic oscillations during economics decisions
Manuela Rosa MS
Centro Clinico per la Neurostimolazione, le Neurotecnologie ed i Disordini del Movimento, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy
Search for more papers by this authorManuela Fumagalli PsyD
Centro Clinico per la Neurostimolazione, le Neurotecnologie ed i Disordini del Movimento, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Universitá degli Studi di Milano, Milan, Italy
Search for more papers by this authorGaia Giannicola MS
Centro Clinico per la Neurostimolazione, le Neurotecnologie ed i Disordini del Movimento, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy
Search for more papers by this authorSara Marceglia MS, PhD
Centro Clinico per la Neurostimolazione, le Neurotecnologie ed i Disordini del Movimento, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy
Search for more papers by this authorClaudio Lucchiari PsyD, PhD
Dipartimento di Scienze Sociali e Politiche, Universitá degli Studi di Milano, Milan, Italy
Search for more papers by this authorDomenico Servello MD
Neurochirurgia Funzionale e Clinica Tourette, IRCCS Galeazzi, Milan, Italy
Search for more papers by this authorAngelo Franzini MD
Fondazione IRCCS Istituto Nazionale Neurologico Carlo Besta, Milan, Italy
Search for more papers by this authorClaudio Pacchetti MD
Unitá Operativa Parkinson e Disordini del Movimento, IRCCS Istituto Neurologico Mondino, Pavia, Italy
Search for more papers by this authorLuigi Romito MD, PhD
Fondazione IRCCS Istituto Nazionale Neurologico Carlo Besta, Milan, Italy
Search for more papers by this authorAlberto Albanese MD
Fondazione IRCCS Istituto Nazionale Neurologico Carlo Besta, Milan, Italy
Search for more papers by this authorMauro Porta MD
Neurochirurgia Funzionale e Clinica Tourette, IRCCS Galeazzi, Milan, Italy
Search for more papers by this authorGabriella Pravettoni PsyD, PhD
Dipartimento di Scienze Sociali e Politiche, Universitá degli Studi di Milano, Milan, Italy
Search for more papers by this authorCorresponding Author
Alberto Priori MD, PhD
Centro Clinico per la Neurostimolazione, le Neurotecnologie ed i Disordini del Movimento, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Universitá degli Studi di Milano, Milan, Italy
Correspondence to: Prof. A. Priori, Centro Clinico per la Neurostimolazione, le Neurotecnologie ed i Disordini del Movimento, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122 Milan, Italy; [email protected]Search for more papers by this authorManuela Rosa MS
Centro Clinico per la Neurostimolazione, le Neurotecnologie ed i Disordini del Movimento, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy
Search for more papers by this authorManuela Fumagalli PsyD
Centro Clinico per la Neurostimolazione, le Neurotecnologie ed i Disordini del Movimento, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Universitá degli Studi di Milano, Milan, Italy
Search for more papers by this authorGaia Giannicola MS
Centro Clinico per la Neurostimolazione, le Neurotecnologie ed i Disordini del Movimento, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy
Search for more papers by this authorSara Marceglia MS, PhD
Centro Clinico per la Neurostimolazione, le Neurotecnologie ed i Disordini del Movimento, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy
Search for more papers by this authorClaudio Lucchiari PsyD, PhD
Dipartimento di Scienze Sociali e Politiche, Universitá degli Studi di Milano, Milan, Italy
Search for more papers by this authorDomenico Servello MD
Neurochirurgia Funzionale e Clinica Tourette, IRCCS Galeazzi, Milan, Italy
Search for more papers by this authorAngelo Franzini MD
Fondazione IRCCS Istituto Nazionale Neurologico Carlo Besta, Milan, Italy
Search for more papers by this authorClaudio Pacchetti MD
Unitá Operativa Parkinson e Disordini del Movimento, IRCCS Istituto Neurologico Mondino, Pavia, Italy
Search for more papers by this authorLuigi Romito MD, PhD
Fondazione IRCCS Istituto Nazionale Neurologico Carlo Besta, Milan, Italy
Search for more papers by this authorAlberto Albanese MD
Fondazione IRCCS Istituto Nazionale Neurologico Carlo Besta, Milan, Italy
Search for more papers by this authorMauro Porta MD
Neurochirurgia Funzionale e Clinica Tourette, IRCCS Galeazzi, Milan, Italy
Search for more papers by this authorGabriella Pravettoni PsyD, PhD
Dipartimento di Scienze Sociali e Politiche, Universitá degli Studi di Milano, Milan, Italy
Search for more papers by this authorCorresponding Author
Alberto Priori MD, PhD
Centro Clinico per la Neurostimolazione, le Neurotecnologie ed i Disordini del Movimento, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Universitá degli Studi di Milano, Milan, Italy
Correspondence to: Prof. A. Priori, Centro Clinico per la Neurostimolazione, le Neurotecnologie ed i Disordini del Movimento, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122 Milan, Italy; [email protected]Search for more papers by this authorFunding agencies: The study was supported by an ERANET-Neuron Grant, Physiological Mechanisms of Deep Brain Stimulation (PhysiolDBS) (Neuron-48-013) from Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico (Milan, Italy), Universitá degli Studi di Milano (Italy), Ministero della Sanitá (Italy), Ministero dell'Universitá, e della Ricerca Scientifica e Tecnologica (Italy).
Relevant conflicts of interest/financial disclosures: Nothing to report.
Full financial disclosures and author roles may be found in the online version of this article.
Manuela Rosa, Manuela Fumagalli, and Gaia Giannicola contributed equally to this work.
ABSTRACT
Pathological gambling develops in up to 8% of patients with Parkinson's disease. Although the pathophysiology of gambling remains unclear, several findings argue for a dysfunction in the basal ganglia circuits. To clarify the role of the subthalamic nucleus in pathological gambling, we studied its activity during economics decisions. We analyzed local field potentials recorded from deep brain stimulation electrodes in the subthalamic nucleus while parkinsonian patients with (n = 8) and without (n = 9) pathological gambling engaged in an economics decision-making task comprising conflictual trials (involving possible risk-taking) and non conflictual trials. In all parkinsonian patients, subthalamic low frequencies (2–12 Hz) increased during economics decisions. Whereas, in patients without gambling, low-frequency oscillations exhibited a similar pattern during conflictual and non conflictual stimuli, in those with gambling, low-frequency activity increased significantly more during conflictual than during non conflictual stimuli. The specific low-frequency oscillatory pattern recorded in patients with Parkinson's disease who gamble could reflect a subthalamic dysfunction that makes their decisional threshold highly sensitive to risky options. When parkinsonian patients process stimuli related to an economics task, low-frequency subthalamic activity increases. This task-related change suggests that the cognitive-affective system that drives economics decisional processes includes the subthalamic nucleus. The specific subthalamic neuronal activity during conflictual decisions in patients with pathological gambling supports the idea that the subthalamic nucleus is involved in behavioral strategies and in the pathophysiology of gambling. © 2013 International Parkinson and Movement Disorder Society
Supporting Information
Additional Supporting Information may be found in the online version of this article.
| Filename | Description |
|---|---|
| mds25427-sup-0001-suppinfo.doc46.5 KB | Supplementary Information |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1 Foffani G, Bianchi AM, Baselli G, Priori A. Movement-related frequency modulation of beta oscillatory activity in the human subthalamic nucleus. J Physiol 2005; 568(pt 2): 699–711.
- 2 Groenewegen HJ. The basal ganglia and motor control. Neural Plast 2003; 10(1–2): 107–120.
- 3 Kuhn AA, Kempf F, Brucke C, et al. High-frequency stimulation of the subthalamic nucleus suppresses oscillatory beta activity in patients with Parkinson's disease in parallel with improvement in motor performance. J Neurosci 2008; 28: 6165–6173.
- 4 Brucke C, Kupsch A, Schneider GH, et al. The subthalamic region is activated during valence-related emotional processing in patients with Parkinson's disease. Eur J Neurosci 2007; 26: 767–774.
- 5 Fumagalli M, Giannicola G, Rosa M, et al. Conflict-dependent dynamic of subthalamic nucleus oscillations during moral decisions. Soc Neurosci 2011; 6: 243–256.
- 6 Fumagalli M, Priori A. Functional and clinical neuroanatomy of morality. Brain 2012; 135(pt 7): 2006–2021.
- 7 Kuhn AA, Hariz MI, Silberstein P, et al. Activation of the subthalamic region during emotional processing in Parkinson disease. Neurology 2005; 65: 707–713.
- 8 Marceglia S, Fiorio M, Foffani G, et al. Modulation of beta oscillations in the subthalamic area during action observation in Parkinson's disease. Neuroscience 2009; 161: 1027–1036.
- 9 Cavanagh JF, Wiecki TV, Cohen MX, et al. Subthalamic nucleus stimulation reverses mediofrontal influence over decision threshold. Nat Neurosci 2011; 14: 1462–1467.
- 10 Frank MJ, Samanta J, Moustafa AA, Sherman SJ. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science 2007; 318: 1309–1312.
- 11 Halbig TD, Tse W, Frisina PG, et al. Subthalamic deep brain stimulation and impulse control in Parkinson's disease. Eur J Neurol 2009; 16: 493–497.
- 12 Oyama G, Shimo Y, Natori S, et al. Acute effects of bilateral subthalamic stimulation on decision-making in Parkinson's disease. Parkinsonism Relat Disord 2011; 17: 189–193.
- 13 Rogers RD, Wielenberg B, Wojtecki L, Elben S, Campbell-Meiklejohn D, Schnitzler A. Deep brain stimulation of the subthalamic nucleus transiently enhances loss-chasing behaviour in patients with Parkinson's disease. Exp Neurol 2011; 231: 181–189.
- 14 Smeding HM, Goudriaan AE, Foncke EM, Schuurman PR, Speelman JD, Schmand B. Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease. J Neurol Neurosurg Psychiatry 2007; 78: 517–519.
- 15 van Wouwe NC, Ridderinkhof KR, van den Wildenberg WP, et al. Deep brain stimulation of the subthalamic nucleus improves reward-based decision-learning in Parkinson's disease [serial online]. Front Hum Neurosci 2011; 5: 30.
- 16 Frank MJ. Hold your horses: a dynamic computational role for the subthalamic nucleus in decision making. Neural Netw 2006; 19: 1120–1136.
- 17 Schroeder U, Kuehler A, Haslinger B, et al. Subthalamic nucleus stimulation affects striato-anterior cingulate cortex circuit in a response conflict task: a PET study. Brain 2002; 125(pt 9): 1995–2004.
- 18 Thobois S, Hotton GR, Pinto S, et al. STN stimulation alters pallidal-frontal coupling during response selection under competition. J Cereb Blood Flow Metab 2007; 27: 1173–1184.
- 19 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Revised 4th ed. Washington, DC: American Psychiatric Association; 2000.
- 20 Djamshidian A, Jha A, O'Sullivan SS, et al. Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease. Mov Disord 2010; 25: 2203–2210.
- 21 Alvarez-Moya EM, Ochoa C, Jimenez-Murcia S, et al. Effect of executive functioning, decision-making and self-reported impulsivity on the treatment outcome of pathologic gambling. J Psychiatry Neurosci 2011; 365: 165–175.
- 22 Ardouin C, Voon V, Worbe Y, et al. Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation. Mov Disord 2006; 21: 1941–1946.
- 23 Bandini F, Primavera A, Pizzorno M, Cocito L. Using STN DBS and medication reduction as a strategy to treat pathological gambling in Parkinson's disease. Parkinsonism Relat Disord 2007; 13: 369–371.
- 24 Lim SY, O'Sullivan SS, Kotschet K, et al. Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease. J Clin Neurosci 2009; 16: 1148–1152.
- 25 Rosa M, Giannicola G, Marceglia S, et al. Neurophysiology of deep brain stimulation. Int Rev Neurobiol 2012; 107: 23–55.
- 26 Foffani G, Priori A, Egidi M, et al. 300-Hz subthalamic oscillations in Parkinson's disease. Brain 2003; 126(pt 10): 2153–2163.
- 27 Giannicola G, Marceglia S, Rossi L, et al. The effects of levodopa and ongoing deep brain stimulation on subthalamic beta oscillations in Parkinson's disease. Exp Neurol 2010; 226: 120–127.
- 28 Priori A, Foffani G, Pesenti A, et al. Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease. Exp Neurol 2004; 189: 369–379.
- 29 Lesieur HR, Blume SB. The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry 1987; 144: 1184–1188.
- 30 Folstein MF, Folstein SE, McHugh PR. “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189–198.
- 31 Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361–370.
- 32 Aitken RC. Measurement of feelings using visual analogue scales. Proc R Soc Med 1969; 62: 989–993.
- 33 Pedrabissi L, Santinello M. Manuale per la Nuova Versione Italiana dello S.T.A.I.—Forma Y. Firenze, Italy: Organizzazioni Speciali; 1989.
- 34 Spielberger CD. STAI State-Trait Anxiety Inventory Forma Y. Firenze, Italy: Organizzazioni Speciali; 1996.
- 35 Rodriguez-Oroz MC, Lopez-Azcarate J, Garcia-Garcia D, et al. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease. Brain 2011; 134(pt 1): 36–49.
- 36 Voon V, Mehta AR, Hallett M. Impulse control disorders in Parkinson's disease: recent advances. Curr Opin Neurol 2011; 24: 324–330.
- 37 Marceglia S, Fumagalli M, Priori A. What neurophysiological recordings tell us about cognitive and behavioral functions of the human subthalamic nucleus. Exp Rev Neurother 2011; 11: 139–149.
- 38 Giannicola G, Rosa M, Marceglia S, et al. The effects of levodopa and deep brain stimulation on subthalamic local field low-frequency oscillations in Parkinson's Disease [published online ahead of print April 26, 2012]. Neurosignals 2012.
- 39 Pine A, Shiner T, Seymour B, Dolan RJ. Dopamine, time, and impulsivity in humans. J Neurosci 2010; 30: 8888–8896.
- 40 Takahashi H, Matsui H, Camerer C, et al. Dopamine D receptors and nonlinear probability weighting in risky choice. J Neurosci 2010; 30: 16567–16572.
- 41 Marceglia S, Rossi L, Foffani G, Bianchi A, Cerutti S, Priori A. Basal ganglia local field potentials: applications in the development of new deep brain stimulation devices for movement disorders. Expert Rev Med Devices 2007; 4: 605–614.
- 42 Priori A, Foffani G, Rossi L, Marceglia S. Adaptive deep brain stimulation (aDBS) controlled by local field potential oscillations [published online ahead of print September 27, 2012]. Exp Neurol 2012.
- 43 Rosa M, Giannicola G, Servello D, et al. Subthalamic local field beta oscillations during ongoing deep brain stimulation in Parkinson's disease in hyperacute and chronic phases. Neurosignals 2011; 19: 151–162.
- 44 Rosa M, Marceglia S, Servello D, et al. Time dependent subthalamic local field potential changes after DBS surgery in Parkinson's disease. Exp Neurol 2010; 222: 184–190.
- 45 Potenza MN, Sofuoglu M, Carroll KM, Rounsaville BJ. Neuroscience of behavioral and pharmacological treatments for addictions. Neuron 2011; 69: 695–712.
- 46 Steeves TD, Miyasaki J, Zurowski M, et al. Increased striatal dopamine release in parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 2009; 132(pt 5): 1376–1385.
- 47 Baunez C, Amalric M, Robbins TW. Enhanced food-related motivation after bilateral lesions of the subthalamic nucleus. J Neurosci 2002; 22: 562–568.
- 48 Bezzina G, Boon FS, Hampson CL, et al. Effect of quinolinic acid-induced lesions of the subthalamic nucleus on performance on a progressive-ratio schedule of reinforcement: a quantitative analysis. Behav Brain Res 2008; 195: 223–230.
- 49 Lardeux S, Pernaud R, Paleressompoulle D, Baunez C. Beyond the reward pathway: coding reward magnitude and error in the rat subthalamic nucleus. J Neurophysiol 2009; 102: 2526–2537.
- 50 Baunez C, Dias C, Cador M, Amalric M. The subthalamic nucleus exerts opposite control on cocaine and “natural” rewards. Nat Neurosci 2005; 8: 484–489.
- 51 Lardeux S, Baunez C. Alcohol preference influences the subthalamic nucleus control on motivation for alcohol in rats. Neuropsychopharmacology 2008; 33: 634–642.
- 52 Uslaner JM, Dell'Orco JM, Pevzner A, Robinson TE. The influence of subthalamic nucleus lesions on sign-tracking to stimuli paired with food and drug rewards: facilitation of incentive salience attribution? Neuropsychopharmacology 2008; 33: 2352–2361.
- 53 Uslaner JM, Yang P, Robinson TE. Subthalamic nucleus lesions enhance the psychomotor-activating, incentive motivational, and neurobiological effects of cocaine. J Neurosci 2005; 25: 8407–8415.
- 54 Rouaud T, Lardeux S, Panayotis N, Paleressompoulle D, Cador M, Baunez C. Reducing the desire for cocaine with subthalamic nucleus deep brain stimulation. Proc Natl Acad Sci USA 2010; 107: 1196–1200.
- 55 Mallet L, Schüpbach M, N'Diaye K, et al. Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior. Proc Natl Acad Sci USA 2007; 104: 10661–10666.
